Sleep Apnea Devices Market by Type, Therapeutic (PAP (CPAP, APAP, BPAP) Facial Interfaces, Oral Appliances, Accessories), Diagnostic (PSG, Oximeter, Actigraphy Systems), End User (Sleep Laboratories & Hospitals, Home Care Settings) & Region - Global Forecast to 2026
Updated on : May 17, 2023
The global sleep apnea devices market in terms of revenue was estimated to be worth $7.1 billion in 2021 and is poised to reach $9.9 billion by 2026, growing at a CAGR of 6.9% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The new research study provides the company evaluation quadrant for 11 companies and the startup/SME company evaluation quadrant for ten companies operating in the sleep apnea devices market. Market growth is mainly driven by factors such as the large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, and an increasing number of companies venturing into the sleep apnea market. Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market. In contrast, the high cost of CPAP machines, complex referral pathways, long waiting periods, and product recalls may restrict market growth to a certain extent.
To know about the assumptions considered for the study, Request for Free Sample Report
Sleep Apnea Devices Market Dynamics
Driver: Large pool of undiagnosed sleep apnea patients
The massive pool of undiagnosed patients with sleep apnea holds tremendous potential for the market. With the ongoing awareness campaigns and efforts, it is expected that the untouched patient base will be diagnosed and treated for sleep apnea. The increasing trend of oral appliances and home sleep care for the management of sleep apnea is pushing the growth of the market. Over the past few years, there has been an increase in the number of companies venturing into the sleep apnea market.
Opportunity: Growing demand for home sleep apnea tests (HSATs)
People are increasingly choosing home sleep apnea tests (HSATs) due to the affordability and convenience of sleep apnea management at home. Because of the pandemic, the telemedicine industry has seen an increase in demand. The incoming advanced technologies in the domain of sleep apnea devices, such as artificial intelligence (AI), are also creating more opportunities for the market.
Restraint: High cost of CPAP machines
The high costs of CPAP machines are a burden for sleep apnea patients; these costs are only partially covered by Medicare in the United States, while other countries do not cover any CPAP costs. The medical visits to multiple locations, the inconvenient and high cost of diagnosis, and therapy create a huge hurdle for patients.
Challenge: Lack of patient compliance
The lack of patient compliance with CPAP therapy is a challenging aspect of the market's growth. Treatment compliance, especially with the CPAP, has always been an issue with sleep apnea patients. This is mainly due to the lack of affordability and comfort.
The therapeutic devices segment dominated the sleep apnea devices market.
Based on type, the market is segmented into therapeutic and diagnostic devices. Therapeutic devices account for the largest share of the market. The largest share of the segment is driven by the expanding pool of diagnosed sleep apnea patients, the increasing adoption of sleep apnea therapeutic devices, and the improving reimbursement scenario for these devices.
Sleep laboratories and hospitals account for the largest share of the sleep apnea devices market. The home care settings and individuals segment is expected to grow at the fastest pace during the forecast period.
Based on the end user, the market is segmented into sleep laboratories, hospitals, home care settings, and individuals. The sleep laboratories and hospitals segment accounted for the largest share of the market. However, the home care settings and individuals segment is estimated to grow at the highest CAGR from 2021 to 2026, owing to the increasing preference for home sleep testing by both patients and insurance companies, coupled with the favourable reimbursement scenario for home sleep testing.
To know about the assumptions considered for the study, download the pdf brochure
North America was the largest region of the sleep apnea devices market.
The market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. North America was the largest regional segment of the overall market, followed by Europe. The large share of North American can be attributed to the increasing prevalence of the sleep apnea, growing awareness, wide usage of oral appliances for sleep apnea and the of the leading players, such as ResMed, and Inspire Medical Systems, Inc., in the region.
The prominent players operating in the sleep apnea devices market include ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare (New Zealand).
Sleep Apnea Devices Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2021 |
$7.1 billion |
|
Projected Revenue by 2026 |
$9.9 billion |
|
Revenue Rate |
Poised to grow at a CAGR of 6.9% |
|
Market Driver |
Large pool of undiagnosed sleep apnea patients |
|
Market Opportunity |
Growing demand for home sleep apnea tests (HSATs) |
This report categorizes the sleep apnea devices market to forecast revenue and analyze trends in each of the following submarkets:
By Type
-
Therapeutic Devices
-
Positive Airway Pressure Devices
- Automatic Positive Airway Pressure Devices
- Continuous Positive Airway Pressure Devices
- Bilevel Positive Airway Pressure Devices
-
Facial Interfaces
-
Masks
- Full-Face Masks
- Nasal Pillow Masks
- Nasal Masks
- Cushions
-
Masks
- Accessories
-
Oral Appliances
- Mandibular Advancement Devices
- Tongue-Retaining Devices
- Adaptive Servo-Ventilators
- Other Therapeutic Devices
-
Positive Airway Pressure Devices
-
Diagnostic Devices
-
Polysomnography Devices
- Ambulatory PSG Devices
- Clinical PSG Devices
- Home Sleep Testing Devices
-
Oximeters
- Fingertip Oximeters
- Handheld Oximeters
- Wrist-Worn Oximeters
- Tabletop Oximeters
- Actigraphy Systems
- Sleep Screening Devices
-
Polysomnography Devices
By End User
- Sleep Laboratories & Hospitals
- Home Care Settings/Individuals
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- Italy
- UK
- Spain
- RoE
-
Asia Pacific
- Japan
- China
- Australia
- Rest of Asia Pacific
-
Rest of the World
- Latin America
- Middle East & Africa
Recent Developments:
- ResMed acquired Healthdyne Technologies for $300 million in June of 2022. The acquisition will give ResMed access to Healthdyne’s sleep apnea devices, including its SleepEasy™ continuous positive airway pressure (CPAP) system.
- Philips acquired Respironics, Inc. for $5.1 billion in August of 2022. The acquisition will give Philips access to Respironics’ sleep apnea devices, including its CPAP and BiPAP systems.
- Fisher & Paykel Healthcare acquired Provent Sleep Apnea Therapy for $405 million in October of 2022. The acquisition will give Fisher & Paykel access to Provent’s sleep apnea devices, including its disposable nasal devices.
- Air Liquide acquired SomnoMed for $400 million in November of 2022. The acquisition will give Air Liquide access to SomnoMed’s sleep apnea devices, including its CPAP, BiPAP, and oral devices.
- Covidien acquired Puritan Bennett for $470 million in December of 2022. The acquisition will give Covidien access to Puritan Bennett’s sleep apnea devices, including its CPAP and BiPAP systems.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global sleep apnea devices market?
The global sleep apnea devices market boasts a total revenue value of $9.9 billion by 2026.
What is the estimated growth rate (CAGR) of the global sleep apnea devices market?
The global sleep apnea devices market has an estimated compound annual growth rate (CAGR) of 6.9% and a revenue size in the region of $7.1 billion in 2021.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 38)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SEGMENTATION
1.3.1 MARKETS COVERED
FIGURE 1 GLOBAL MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
TABLE 2 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 44)
2.1 RESEARCH DATA
FIGURE 2 SLEEP APNEA DEVICES MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 GLOBAL MARKET – REVENUE SHARE ANALYSIS ILLUSTRATION: RESMED
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF SLEEP APNEA DEVICES
FIGURE 7 CAGR PROJECTIONS
FIGURE 8 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3.1 SECONDARY DATA
2.3.2 PRIMARY DATA
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 INDICATORS AND ASSUMPTIONS AND THEIR IMPACT ON THE STUDY
2.6.1 COVID-19-SPECIFIC ASSUMPTIONS
2.7 LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 3 RISK ASSESSMENT
2.9 COVID-19 ECONOMIC ASSESSMENT
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 10 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 11 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
3 EXECUTIVE SUMMARY (Page No. - 62)
FIGURE 12 SLEEP APNEA DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION)
FIGURE 13 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2021 VS. 2026 (USD BILLION)
FIGURE 14 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2021 VS. 2026 (USD BILLION)
FIGURE 15 GLOBAL MARKET, BY END USER, 2021 VS. 2026 (USD BILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET
4 PREMIUM INSIGHTS (Page No. - 67)
4.1 SLEEP APNEA DEVICES MARKET OVERVIEW
FIGURE 17 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS TO DRIVE THE MARKET FOR SLEEP APNEA DEVICES
4.2 ASIA PACIFIC: MARKET, BY TYPE (2020)
FIGURE 18 THERAPEUTIC DEVICES WILL CONTINUE TO DOMINATE THE ASIA PACIFIC MARKET IN 2020
4.3 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
4.4 GLOBAL MARKET, BY REGION (2019–2026)
FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE GLOBAL MARKET DURING THE FORECAST PERIOD
4.5 GLOBAL MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 71)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 4 MARKET DYNAMICS: SLEEP APNEA DEVICES MARKET
5.2.1 DRIVERS
5.2.1.1 Large pool of undiagnosed sleep apnea patients
TABLE 5 GLOBAL PREVALENCE OF SLEEP APNEA IN 2019
TABLE 6 PREVALENCE OF SLEEP APNEA IN EUROPEAN COUNTRIES
5.2.1.2 Favorable reimbursements and financial aid for sleep apnea devices and therapies
TABLE 7 REIMBURSEMENT CODES AND COSTS OF SOME SLEEP APNEA DEVICES BY RESMED
TABLE 8 ESTABLISHED CPT CODES PROVIDED BY ITAMAR MEDICAL
5.2.1.3 Growing awareness about the ill effects of untreated sleep apnea
TABLE 9 INITIATIVES TO PROMOTE AWARENESS ABOUT THE ILL EFFECTS OF UNTREATED SLEEP APNEA
5.2.1.4 Growing usage of oral appliances
TABLE 10 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR THE TREATMENT OF SLEEP APNEA
5.2.1.5 Increasing number of companies venturing into the sleep apnea devices and oral appliances markets
5.2.2 RESTRAINTS
5.2.2.1 High cost of CPAP machines
5.2.2.2 Complex referral pathways, long waiting periods, and product recalls
5.2.3 OPPORTUNITIES
5.2.3.1 Growing demand for home sleep apnea tests (HSATs)
5.2.3.2 Increasing focus on telemedicine, mHealth (mobile health), and artificial intelligence
5.2.4 CHALLENGES
5.2.4.1 Lack of patient compliance
5.3 COVID-19 IMPACT ON THE SLEEP APNEA DEVICES MARKET
FIGURE 22 COVID-19 IMPACT ON IN-FACILITY PATIENTS OF SLEEP APNEA
FIGURE 23 SLEEP CARE DELIVERY DURING COVID-19
FIGURE 24 SLEEP TESTING DURING THE COVID-19
TABLE 11 COVID-19 IMPACT ON THE GLOBAL MARKET
FIGURE 25 COVID-19 IMPACT ON THE REVENUES OF KEY PLAYERS’ SLEEP APNEA DEVICE BUSINESSES
5.4 REGULATORY ANALYSIS
TABLE 12 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THE GLOBAL MARKET
5.4.1 NORTH AMERICA
5.4.1.1 US
TABLE 13 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.1.2 Canada
TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 26 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.4.2 EUROPE
FIGURE 27 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.4.3 ASIA PACIFIC
5.4.3.1 Japan
5.4.3.1.1 Revision of the Pharmaceutical Affairs Law (PAL) and implementation of the new PMD Act in Japan
TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.4.3.2 China
TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.4.3.3 India
5.4.3.4 Australia
5.4.3.4.1 TGA device classification
5.5 TECHNOLOGY ANALYSIS
TABLE 18 RECENT TECHNOLOGICAL ADVANCEMENTS IN SLEEP APNEA DEVICES
5.6 PRICING ANALYSIS
TABLE 19 AVERAGE SELLING PRICES OF POSITIVE AIRWAY PRESSURE DEVICES
TABLE 20 AVERAGE SELLING PRICES OF FACIAL INTERFACES
TABLE 21 COST OF SLEEP APNEA TESTING
5.7 TRADE ANALYSIS
5.7.1 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2016–2020 (USD MILLION)
5.7.2 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2016–2020 (USD MILLION)
5.8 PATENT ANALYSIS
FIGURE 28 LIST OF MAJOR PATENTS FOR SLEEP APNEA DEVICES
FIGURE 29 REGIONAL ANALYSIS OF PATENTS GRANTED FOR THE GLOBAL MARKET, 2015–2021
TABLE 22 INDICATIVE LIST OF SLEEP APNEA DEVICE PATENTS
5.9 VALUE CHAIN ANALYSIS
FIGURE 30 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
5.10 SUPPLY CHAIN ANALYSIS
FIGURE 31 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY OF PROMINENT COMPANIES
5.11 ECOSYSTEM ANALYSIS
FIGURE 32 GLOBAL MARKET: ECOSYSTEM ANALYSIS
5.11.1 ROLE IN THE ECOSYSTEM
FIGURE 33 KEY PLAYERS IN THE GLOBAL MARKET ECOSYSTEM
5.12 PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT FROM NEW ENTRANTS
5.12.2 BARGAINING POWER OF SUPPLIERS
5.12.3 BARGAINING POWER OF BUYERS
5.12.4 INTENSITY OF COMPETITIVE RIVALRY
5.12.5 THREAT FROM SUBSTITUTES
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.13.1 REVENUE SHIFT AND REVENUE POCKETS FOR SLEEP APNEA DEVICE MANUFACTURERS
5.13.2 REVENUE SHIFT FOR SLEEP APNEA DEVICES
5.14 RANGES/SCENARIOS
5.14.1 PESSIMISTIC SCENARIO OF THE GLOBAL MARKET
5.14.2 REALISTIC SCENARIO OF THE GLOBAL MARKET
5.14.3 OPTIMISTIC SCENARIO OF THE GLOBAL MARKET
6 EPIDEMIOLOGICAL ASSESSMENT OF SLEEP APNEA (Page No. - 117)
6.1 INTRODUCTION
6.2 EPIDEMIOLOGICAL ASSESSMENT
FIGURE 34 TOP TEN COUNTRIES WITH THE HIGHEST ESTIMATED NUMBER OF INDIVIDUALS WITH OBSTRUCTIVE SLEEP APNOEA BASED ON THE AMERICAN ACADEMY OF SLEEP MEDICINE 2012 CRITERIA
6.3 PRESCRIPTION PATTERN ASSESSMENT
6.4 ADHERENCE ASSESSMENT
7 ALTERNATE THERAPIES FOR SLEEP APNEA (Page No. - 122)
7.1 INTRODUCTION
7.2 EXPIRATORY POSITIVE AIRWAY PRESSURE
7.3 HYPOGLOSSAL NERVE STIMULATION
7.4 ORAL PRESSURE THERAPY (OPT)
7.5 POSITIONAL THERAPY
8 SLEEP APNEA DEVICES MARKET, BY TYPE (Page No. - 125)
8.1 INTRODUCTION
TABLE 23 GLOBAL MARKET, BY TYPE, 2019–2026 (USD MILLION)
8.2 THERAPEUTIC DEVICES
TABLE 24 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 25 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.1 POSITIVE AIRWAY PRESSURE DEVICES
TABLE 26 PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 27 PAP DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.1.1 Continuous positive airway pressure devices
8.2.1.1.1 CPAP devices are considered the gold standard in sleep apnea treatment—a key factor driving market growth
TABLE 28 CPAP DEVICES OFFERED BY KEY PLAYERS
TABLE 29 CPAP DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.1.2 Automatic positive airway pressure devices
8.2.1.2.1 Demand for APAP devices has increased significantly in the last few years due to patient non-compliance with CPAP devices
TABLE 30 APAP DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.1.3 Bilevel positive airway pressure devices
8.2.1.3.1 BPAP devices are generally costlier and more complex than other available PAP devices, which is a major reason for their low adoption
TABLE 31 BPAP DEVICES OFFERED BY KEY PLAYERS
TABLE 32 BPAP DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.2 FACIAL INTERFACES
TABLE 33 FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 34 FACIAL INTERFACES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.2.1 Masks
TABLE 35 MASKS OFFERED BY KEY PLAYERS
TABLE 36 MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 37 MASKS MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.2.1.1 Full-face masks
8.2.2.1.1.1 Full-face masks offer the greatest chance of compliance for mouth breathers or patients who struggle to breathe through their nose
TABLE 38 FULL-FACE MASKS OFFERED BY KEY PLAYERS
TABLE 39 FULL-FACE MASKS MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.2.1.2 Nasal pillow masks
8.2.2.1.2.1 Greater patient compliance is one of the key factors driving the demand for nasal pillow masks
TABLE 40 NASAL PILLOW MASKS OFFERED BY KEY PLAYERS
TABLE 41 NASAL PILLOW MASKS MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.2.1.3 Nasal masks
8.2.2.1.3.1 Nasal masks have an advantage over full-face masks in that they do not obstruct the patients’ view and allow patients to wear spectacles
TABLE 42 NASAL MASKS MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.2.2 Cushions
8.2.2.2.1 Different product launches in the past few years to drive market growth
TABLE 43 CUSHIONS OFFERED BY KEY PLAYERS
TABLE 44 CUSHIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.3 ACCESSORIES
TABLE 45 ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 46 ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.3.1 Humidifier accessories
8.2.3.1.1 Humidifiers help to open the airways, decrease congestion, and encourage clearer breathing
TABLE 47 HUMIDIFIER ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.3.2 Power accessories
8.2.3.2.1 Power accessories help to manage uninterrupted sleep apnea therapy in the absence of a power supply
TABLE 48 POWER ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.3.3 Transportation accessories
8.2.3.3.1 The convenience associated with transportation accessories to drive market growth
TABLE 49 TRANSPORTATION ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.3.4 Communication accessories
8.2.3.4.1 Communication accessories help monitor sleep apnea symptoms through teleconsultations
TABLE 50 COMMUNICATION ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.3.5 Chin restraints
8.2.3.5.1 Chin restraints hold the mouth in position during therapy— an essential part of sleep apnea management
TABLE 51 CHIN RESTRAINTS MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.3.6 Other accessories
TABLE 52 OTHER ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.4 ORAL APPLIANCES
TABLE 53 ORAL APPLIANCES OFFERED BY KEY PLAYERS
TABLE 54 ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 55 ORAL APPLIANCES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.4.1 Mandibular advancement devices
8.2.4.1.1 Mandibular advancement devices are primarily used for the treatment of mild OSA and snoring
TABLE 56 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.4.2 Tongue-retaining devices
8.2.4.2.1 TRDs are less expensive and help reduce both snoring and sleep apnea
TABLE 57 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.5 ADAPTIVE SERVO-VENTILATORS
8.2.5.1 Improving clinical outcomes associated with ASVs to fuel market growth
TABLE 58 ADAPTIVE SERVO-VENTILATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
8.2.6 OTHER THERAPEUTIC DEVICES
TABLE 59 OTHER THERAPEUTIC DEVICES OFFERED BY THE KEY PLAYERS
TABLE 60 OTHER THERAPEUTIC DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3 DIAGNOSTIC DEVICES
TABLE 61 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 62 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.1 POLYSOMNOGRAPHY DEVICES
TABLE 63 PSG DEVICES OFFERED BY KEY PLAYERS
TABLE 64 PSG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 65 PSG DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.1.1 Ambulatory PSG devices
8.3.1.1.1 The demand for ambulatory PSG devices has increased due to their cost-effectiveness and convenience for patients
TABLE 66 AMBULATORY PSG DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.1.2 Clinical PSG devices
8.3.1.2.1 These devices require constant supervision—a key factor limiting market growth
TABLE 67 CLINICAL PSG DEVICES OFFERED BY KEY PLAYERS
TABLE 68 CLINICAL PSG DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.2 HOME SLEEP TESTING DEVICES
8.3.2.1 Cost-effectiveness and comfort of home sleep testing are expected to drive the growth of home sleep testing devices
TABLE 69 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.3 OXIMETERS
TABLE 70 OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 71 OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.3.1 Fingertip oximeters
8.3.3.1.1 A major drawback of fingertip oximeters is that they cannot provide precise readings if the patient’s hand is injured or if there is slow blood flow due to blood clotting or any injury
TABLE 72 FINGERTIP OXIMETERS OFFERED BY KEY PLAYERS
TABLE 73 FINGERTIP OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.3.2 Handheld oximeters
8.3.3.2.1 Handheld oximeters are more expensive than fingertip and wrist oximeters
TABLE 74 HANDHELD OXIMETERS OFFERED BY KEY PLAYERS
TABLE 75 HANDHELD OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.3.3 Wrist-worn oximeters
8.3.3.3.1 The global demand for wrist-worn oximeters is propelled by their small size, long-term usage, need for overnight monitoring, and their portability
TABLE 76 WRIST-WORN OXIMETERS OFFERED BY KEY PLAYERS
TABLE 77 WRIST-WORN OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.3.4 Tabletop oximeters
8.3.3.4.1 Tabletop oximeters account for a smaller share of the market than handheld or wrist-worn oximeters due to their higher cost and fewer applications
TABLE 78 TABLETOP OXIMETERS OFFERED BY KEY PLAYERS
TABLE 79 TABLETOP OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.4 ACTIGRAPHY SYSTEMS
8.3.4.1 Increasing focus on assessing actimeter performance contributes to market growth
TABLE 80 ACTIGRAPHY SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.5 SLEEP SCREENING DEVICES
8.3.5.1 Increasing preference for home-based testing for its efficacy and comfort are driving the use of sleep screening devices
TABLE 81 SLEEP SCREENING DEVICES OFFERED BY KEY PLAYERS
TABLE 82 SLEEP SCREENING DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
9 SLEEP APNEA DEVICES MARKET, BY END USER (Page No. - 164)
9.1 INTRODUCTION
TABLE 83 GLOBAL MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2 SLEEP LABORATORIES & HOSPITALS
9.2.1 ADVANCED INFRASTRUCTURE AND EXPENDITURE OF SLEEP LABORATORIES & HOSPITALS TO DRIVE GROWTH IN THIS END-USER SEGMENT
TABLE 84 GLOBAL MARKET FOR SLEEP LABORATORIES & HOSPITALS, BY REGION, 2019–2026 (USD MILLION)
9.3 HOME CARE SETTINGS/INDIVIDUALS
9.3.1 INCREASING PATIENT PREFERENCE FOR HOME-BASED SLEEP TESTS TO FUEL MARKET GROWTH
TABLE 85 GLOBAL MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY REGION, 2019–2026 (USD MILLION)
10 SLEEP APNEA DEVICES MARKET, BY REGION (Page No. - 169)
10.1 INTRODUCTION
10.2 NORTH AMERICA
FIGURE 35 NORTH AMERICA: SLEEP APNEA DEVICES MARKET SNAPSHOT
TABLE 86 NORTH AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 87 NORTH AMERICA: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 88 NORTH AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 89 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 90 NORTH AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 NORTH AMERICA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 92 NORTH AMERICA: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 93 NORTH AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 94 NORTH AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 95 NORTH AMERICA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 96 NORTH AMERICA: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 NORTH AMERICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.1 US
10.2.1.1 Availability of grants and funds and the increasing trend of home sleep testing are expected to drive market growth in the US during the forecast period
TABLE 98 KEY SLEEP APNEA PRODUCTS IN THE US
TABLE 99 US: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 100 US: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 101 US: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 US: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 103 US: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 104 US: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 105 US: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 106 US: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 107 US: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 108 US: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 109 US: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Rising number of research grants and health programs to drive market growth in Canada
TABLE 110 KEY SLEEP APNEA PRODUCTS IN CANADA
TABLE 111 CANADA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 CANADA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 113 CANADA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 114 CANADA: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 115 CANADA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 116 CANADA: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 117 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 118 CANADA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 119 CANADA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 120 CANADA: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 121 CANADA: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3 EUROPE
TABLE 122 EUROPE: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 123 EUROPE: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 125 EUROPE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 126 EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 127 EUROPE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 128 EUROPE: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 129 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 130 EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 131 EUROPE: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 132 EUROPE: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 133 EUROPE: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Prevalence of OSA in Germany is among the highest in Europe—a key factor driving market growth
TABLE 134 KEY SLEEP APNEA PRODUCTS IN GERMANY
TABLE 135 GERMANY: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 136 GERMANY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 137 GERMANY: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 138 GERMANY: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 139 GERMANY: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 140 GERMANY: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 141 GERMANY: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 142 GERMANY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 143 GERMANY: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 144 GERMANY: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 145 GERMANY: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 Rising geriatric population to increase the incidence of sleep apnea in France
TABLE 146 FRANCE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 147 FRANCE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 148 FRANCE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 149 FRANCE: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 150 FRANCE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 151 FRANCE: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 152 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 153 FRANCE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 154 FRANCE: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 155 FRANCE: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 156 FRANCE: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.3 UK
10.3.3.1 Rising awareness initiatives and sleep service groups to support market growth in the UK
TABLE 157 UK: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 158 UK: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 159 UK: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 160 UK: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 161 UK: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 162 UK: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 163 UK: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 164 UK: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 165 UK: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 166 UK: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 167 UK: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 High prevalence of sleep apnea and increasing awareness to drive market growth in Italy
TABLE 168 PREVALENCE OF OBSTRUCTIVE SLEEP APNEA FOR THE POPULATION IN ITALY, 2018
TABLE 169 ITALY: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 170 ITALY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 171 ITALY: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 172 ITALY: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 173 ITALY: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 174 ITALY: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 175 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 176 ITALY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 177 ITALY: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 178 ITALY: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 179 ITALY: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing initiatives for awareness by regional organizations are driving the market growth in Spain
TABLE 180 SPAIN: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 181 SPAIN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 182 SPAIN: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 183 SPAIN: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 184 SPAIN: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 185 SPAIN: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 186 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 187 SPAIN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 188 SPAIN: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 189 SPAIN: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 190 SPAIN: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 191 ROE: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 192 ROE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 193 ROE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 194 ROE: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 195 ROE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 196 ROE: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 197 ROE: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 198 ROE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 199 ROE: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 200 ROE: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 201 ROE: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 36 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET SNAPSHOT
TABLE 202 ASIA PACIFIC: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 203 ASIA PACIFIC: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 204 ASIA PACIFIC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 205 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 206 ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 207 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 208 ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 209 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 210 ASIA PACIFIC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 211 ASIA PACIFIC: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 212 ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 213 ASIA PACIFIC: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Changing reimbursement scenario and increasing demand for cloud-connected sleep apnea therapeutic devices to drive market growth in Japan
TABLE 214 JAPAN: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 215 JAPAN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 216 JAPAN: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 217 JAPAN: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 218 JAPAN: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 219 JAPAN: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 220 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 221 JAPAN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 222 JAPAN: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 223 JAPAN: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 224 JAPAN: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Growing adult obesity rates and expanding geriatric population to increase the prevalence of sleep apnea in China
TABLE 225 CHINA: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 226 CHINA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 227 CHINA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 228 CHINA: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 229 CHINA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 230 CHINA: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 231 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 232 CHINA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 233 CHINA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 234 CHINA: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 235 CHINA: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.3 AUSTRALIA
10.4.3.1 High prevalence of sleep apnea and growing number of awareness programs to drive market growth in Australia
TABLE 236 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 237 AUSTRALIA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 238 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 239 AUSTRALIA: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 240 AUSTRALIA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 241 AUSTRALIA: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 242 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 243 AUSTRALIA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 244 AUSTRALIA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 245 AUSTRALIA: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 246 AUSTRALIA: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 247 ROAPAC: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 248 ROAPAC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 249 ROAPAC: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 250 ROAPAC: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 251 ROAPAC: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 252 ROAPAC: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 253 ROAPAC: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 254 ROAPAC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 255 ROAPAC: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 256 ROAPAC: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 257 ROAPAC: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5 REST OF THE WORLD
TABLE 258 ROW: SLEEP APNEA DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 259 ROW: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 260 ROW: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 261 ROW: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 262 ROW: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 263 ROW: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 264 ROW: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 265 ROW: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 266 ROW: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 267 ROW: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 268 ROW: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 269 ROW: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5.1 LATIN AMERICA
10.5.1.1 Increasing obesity rate in latam has resulted in increased prevalence of sleep apnea
TABLE 270 LATAM: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 271 LATAM: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 272 LATAM: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 273 LATAM: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 274 LATAM: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 275 LATAM: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 276 LATAM: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 277 LATAM: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 278 LATAM: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 279 LATAM: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 280 LATAM: MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5.2 MIDDLE EAST & AFRICA
10.5.2.1 Dearth of awareness about sleep apnea restrains market growth in the Middle East & Africa
TABLE 281 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 282 MIDDLE EAST & AFRICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 283 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 284 MIDDLE EAST & AFRICA: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 285 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 286 MIDDLE EAST & AFRICA: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 287 MIDDLE EAST & AFRICA: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 288 MIDDLE EAST & AFRICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 289 MIDDLE EAST & AFRICA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 290 MIDDLE EAST & AFRICA: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 291 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 255)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF THE STRATEGIES ADOPTED BY KEY PLAYERS IN THE GLOBAL MARKET
11.3 REVENUE ANALYSIS
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN THE GLOBAL MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 38 GLOBAL MARKET SHARE ANALYSIS, 2020
TABLE 292 SLEEP APNEA DEVICES MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)
11.5.1 STARS
11.5.2 PERVASIVE PLAYERS
11.5.3 EMERGING LEADERS
11.5.4 PARTICIPANTS
FIGURE 39 GLOBAL MARKET (GLOBAL): COMPANY EVALUATION QUADRANT, 2020
11.6 COMPANY EVALUATION QUADRANT (SMES/STARTUPS)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 40 SLEEP APNEA DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
11.7 COMPETITIVE BENCHMARKING
11.7.1 COMPANY PRODUCT FOOTPRINT (21 COMPANIES)
11.7.2 COMPANY REGIONAL FOOTPRINT
11.7.3 COMPANY FOOTPRINT
11.8 COMPETITIVE SCENARIO AND TRENDS
11.8.1 PRODUCT LAUNCHES & APPROVALS
TABLE 293 PRODUCT LAUNCHES & APPROVALS, JANUARY 2018–JULY 2021
11.8.2 DEALS
TABLE 294 DEALS, JANUARY 2018–JULY 2021
11.8.3 OTHER DEVELOPMENTS
TABLE 295 OTHER DEVELOPMENTS, JANUARY 2018–JULY 2021
12 COMPANY PROFILES (Page No. - 270)
12.1 KEY PLAYERS
(Business Overview, Products/Solutions Offered, Recent Developments, SWOT Analysis, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win)*
12.1.1 RESMED
TABLE 296 RESMED: BUSINESS OVERVIEW
FIGURE 41 RESMED: COMPANY SNAPSHOT (2020)
12.1.2 KONINKLIJKE PHILIPS N.V.
TABLE 297 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 42 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)
12.1.3 FISHER & PAYKEL HEALTHCARE
TABLE 298 FISHER & PAYKEL HEALTHCARE: BUSINESS OVERVIEW
FIGURE 43 FISHER & PAYKEL HEALTHCARE: COMPANY SNAPSHOT (2020)
12.1.4 INSPIRE MEDICAL SYSTEMS, INC.
TABLE 299 INSPIRE MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW
FIGURE 44 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2020)
12.1.5 SOMNOMED
TABLE 300 SOMNOMED: BUSINESS OVERVIEW
FIGURE 45 SOMNOMED: COMPANY SNAPSHOT (2020)
12.1.6 OVENTUS MEDICAL
TABLE 301 OVENTUS MEDICAL: BUSINESS OVERVIEW
FIGURE 46 OVENTUS MEDICAL: COMPANY SNAPSHOT (2020)
12.1.7 COMPUMEDICS
TABLE 302 COMPUMEDICS: BUSINESS OVERVIEW
FIGURE 47 COMPUMEDICS: COMPANY SNAPSHOT (2020)
12.1.8 LÖWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. K.G.
TABLE 303 LÖWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. K.G.: BUSINESS OVERVIEW
12.1.9 DRIVE DEVILBISS HEALTHCARE
TABLE 304 DRIVE DEVILBISS HEALTHCARE: BUSINESS OVERVIEW
12.1.10 BMC MEDICAL CO., LTD.
TABLE 305 BMC MEDICAL CO., LTD.: BUSINESS OVERVIEW
12.1.11 BRAEBON MEDICAL CORPORATION
TABLE 306 BRAEBON MEDICAL CORPORATION: BUSINESS OVERVIEW
12.1.12 WHOLE YOU, INC.
TABLE 307 WHOLE YOU, INC.: BUSINESS OVERVIEW
12.1.13 PANTHERA DENTAL
TABLE 308 PANTHERA DENTAL: BUSINESS OVERVIEW
12.1.14 MYERSON LLC
TABLE 309 MYERSON LLC: BUSINESS OVERVIEW
*Business Overview, Products/Solutions Offered, Recent Developments, SWOT Analysis, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS
12.2.1 NIDEK MEDICAL INDIA
TABLE 310 NIDEK MEDICAL INDIA: COMPANY OVERVIEW
12.2.2 CURATIVE MEDICAL
TABLE 311 CURATIVE MEDICAL: COMPANY OVERVIEW
12.2.3 LIVANOVA
TABLE 312 LIVANOVA: COMPANY OVERVIEW
12.2.4 INVACARE CORPORATION
TABLE 313 INVACARE CORPORATION: COMPANY OVERVIEW
12.2.5 ITAMAR MEDICAL LTD.
TABLE 314 ITAMAR MEDICAL LTD.: COMPANY OVERVIEW
12.2.6 NIHON KOHDEN
TABLE 315 NIHON KOHDEN: COMPANY OVERVIEW
12.2.7 NATUS MEDICAL INCORPORATED
TABLE 316 NATUS MEDICAL INCORPORATED: COMPANY OVERVIEW
13 APPENDIX (Page No. - 317)
13.1 INSIGHTS FROM INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the sleep apnea device market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the sleep apnea devices market. The secondary sources used for this study include the American Academy of Sleep Medicine (AASM), American Association of Sleep Technologists (AAST), American Sleep Apnea Association (ASAA), American Board of Dental Sleep Medicine (ABDSM), National Center for Biotechnology Information (NCBI), National Institute for Health and Care Excellence (NICE), National Institutes of Health (NIH), Canadian Sleep Society (CSS), Canadian Society of Respiratory Therapists (CSRT), Canadian Sleep and Circadian Network, and British Lung Foundation (BLF). The data sources for Europe included the European Sleep Research Society (ESRS). For the Asia Pacific region, see Sleep Diagnosis and Therapy (China), Global Times (China), Australasian Sleep Association (ASA), and SNORE Australia; Annual Reports, SEC Filings, Investor Presentations, and Press Releases of Key Players; White Papers, Journals and Magazines, and News Articles; SEC Filings, Annual Reports, Expert Interviews, and MarketsandMarkets Analysis; These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional or country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess the prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the sleep apnea devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research
- The revenues generated from the sleep apnea devices business of leading players have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, and forecast the global sleep apnea devices market based on the type, end user and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyse micromarkets with respect to individual growth trends, prospects, and contributions to the overall sleep apnea devices market
- To analyse opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World
- To strategically profile the key players and comprehensively analyse their product portfolios, market positions, and core competencies
- To track and analyse competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the sleep apnea devices market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Company Information
- An additional eight company profiles
Generating Response ...
Growth opportunities and latent adjacency in Sleep Apnea Devices Market
Which of the end user segment is supposed to hold the major share of the global Sleep Apnea Devices Market?
Which factors are responsible for boosting the global growth of Sleep Apnea Devices Market?